CAI
Caris Life Sciences
$32.46
+$0.45 (+1.42%)Oct 26, 2026
Key metrics
The numbers that frame CAI today
- Market cap
- $9.17B
- P/E (TTM)
- 19.2
- EV / FCF
- 71.6
- Gross margin
- 69.7%
- EV / Sales
- 9.0
- ROIC
- 25.9%
- Div yield
- 0%
- Debt / equity
- 0.7
- 52wk Low
- $14.19
- 52wk High
- $33.13
Growth
Revenue and earnings trend for CAI
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CAI
Is Caris Life Sciences a good buy?
Yes. Caris Life Sciences has strong quality and excellent momentum. Both signals support the setup. Growth looks excellent, which supports the long-term business case. We think Caris Life Sciences is selling at a fair price.
What is the market capitalization of CAI?
Caris Life Sciences's market capitalization is $9.17B.
What is the P/E (TTM) ratio for CAI stock?
Caris Life Sciences's P/E (TTM) ratio is 19.2, based on trailing earnings.
What is the 52-week high for CAI stock?
The 52-week high for Caris Life Sciences is $33.13. The current close of $32.46 is 2% below that high.
What is the 52-week low for CAI stock?
The 52-week low for Caris Life Sciences is $14.19. The current close of $32.46 is 128.7% above that low.
Does CAI stock pay dividends?
Caris Life Sciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CAI?
Caris Life Sciences's Debt / Equity ratio is 0.66.